Affymetrix announces commercialization of next-generation human transcriptome array Affymetrix.

Predicated on this level of power and performance, the experts concluded the Human Transcriptome Array is more reproducible, faster, and cost-effective than RNA-Seq for detecting and characterizing low-level expression changes of clinically relevant transcripts. ‘An emerging strategy for large-scale clinical genomic research is to first use RNA-Seq to the enough depth of 200 million or greater reads for the discovery of transcriptome elements relevant to the disease process, followed by dependable and high-throughput screening of these elements on thousands of patient samples using custom made designed arrays,’ added Dr.Then make a decision to accept your it in its natural state finally. You shall love the journey that loving oneself will take you!

AMP proposes fresh, service-oriented terminology for top quality laboratory testing Proposes new, service-oriented terminology – – Laboratory Developed Methods The Association for Molecular Pathology released a particular article in the January 2014 problem of the Journal of Molecular Diagnostics titled ‘Revisiting Oversight and Regulation of Molecular-Based Laboratory-Developed Checks’.